Browse studies

Find your next paid study

1,237 recruiting studies matching your filters

Predicting Immunotherapy Efficacy from Analysis of Pre-treatment Tumor Biopsies

This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pr…

Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more

Estimated

~$10 – $1,050

Cofactor Genomics, Inc.NCT04510129

Phase 1

A Phase 1, Open-Label Study of FT836, an Off-the-Shelf CAR T-Cell Therapy, With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

This is a phase 1 study of FT836 administered in participants with advanced solid tumors. The primary objectives of the study are to evaluate the safety and to…

Non-Small Cell Lung CancerColorectal CancerBreast Cancer+3 more

Estimated

~$10 – $8,750

Fate TherapeuticsNCT07216105

Phase 1

A Phase I, Multicenter, Open-label, First-in-Human, Dose Escalation and Expansion Study of DM001 in Patients With Advanced Solid Tumors

The goal of this clinical trial is to find out about the safety, efficacy, and tolerability of DM001 for patients with the advanced solid tumors. DM001 is an e…

Breast NeoplasmsCarcinoma, Non-Small-Cell LungSolid Carcinoma

Estimated

~$10 – $8,750

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.NCT06475937

Phase 2

Phase 2 Pragmatic Trial Investigating Sentinel Lymph Node Biopsy (SLNB) Efficacy and Safety in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

This is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to …

Cutaneous Squamous Cell Carcinoma of the Head and NeckClinically Node-Negative (cN0)High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

Estimated

~$10 – $6,250

University of California, DavisNCT06990737

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despit…

Non-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more

Estimated

~$10 – $750

University of Missouri-ColumbiaNCT02838836

Long-term Follow-up of Subjects Treated With CAR T Cells

This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of C…

Long Term Adverse EffectsCAR-TDuty to Follow Up+4 more

Estimated

~$10 – $1,125

Marcela V. Maus, M.D.,Ph.D.NCT05024175

Observational

Effectiveness of the SoundHeal (Heal) Multi-Sensory Integrative Therapy in Enhancing Emotional Regulation Among Justice-Involved Youth and Its Effect on Therapeutic Alliance and Mental Health Outcomes

Emotional dysregulation in justice-involved youth (JIY) is a condition that significantly impacts young people, their families, and juvenile justice and public…

Emotional DysregulationTherapeutic AllianceDepression Disorder+4 more

A Phase II, Multisite, Open-label Trial of Pumitamig (BNT327) in Combination With Standard-of-care Chemotherapy in First-line and Second-line Non-small Cell Lung Cancer (NSCLC)

This is a Phase II, multisite, open-label study consisting of two parts in participants with advanced/metastatic Non-small Cell Lung Cancer (NSCLC) which progr…

Non-small Cell Lung Cancer

Estimated

~$10 – $7,500

BioNTech SENCT06841055

Phase 1

Feasibility Trial of Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

This is a feasibility trial studying anti-PD-1 therapy (Pembrolizumab) among patients with R/M HNSCC, delivered with ultrasound-induced microbubble cavitation,…

Head and Neck CancerHead and Neck Small Cell CarcinomaMetastatic Head and Neck Cancer+1 more

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07501650

Phase 1

A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

The clinical trial is intended to assess for clinical evidence of Clemastine Fumarate as a myelin repair therapy in patients with acute inflammatory injury-cau…

Demyelinating DiseasesDemyelination; Corpus CallosumMultiple Sclerosis Brain Lesion+2 more

Estimated

~$10 – $5,625

University of California, San FranciscoNCT06065670

Phase 1

Phase 1 Trial Evaluating the Safety and Tolerability of Gamma Delta T-Cell Infusions in Combination With Low Dose Radiotherapy in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer or Solid Tumors With Bone Metastases

This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally ad…

Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors

Estimated

~$10 – $8,750

Kiromic BioPharma Inc.NCT06069570

Phase 1

A Pilot Study Evaluating Mosunetuzumab for Clearance of Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia

The goal of this study is to test mosunetuzumab given alone or in combination with a Bruton tyrosine kinase inhibitor (BTKi, such as ibrutinib, acalabrutinib, …

LeukemiaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+1 more

Estimated

~$10 – $7,500

Inhye AhnNCT07052695